The JAK2V617F mutation also enforced Mcl-1 transcription to sensitize myelodysplastic syndrome cell lines to apoptosis induced by a Bcl-xL/Bcl-2 inhibitor [18]. The gene discussed is MCL1; the disease is myelodysplastic syndrome.